First Time Loading...

Dexcom Inc
NASDAQ:DXCM

Watchlist Manager
Dexcom Inc Logo
Dexcom Inc
NASDAQ:DXCM
Watchlist
Price: 136.35 USD -1.1% Market Closed
Updated: Apr 25, 2024

Intrinsic Value

DexCom, Inc. is a medical device manufacturing company, which engages in the design, development and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. [ Read More ]

The intrinsic value of one DXCM stock under the Base Case scenario is 45.19 USD. Compared to the current market price of 136.35 USD, Dexcom Inc is Overvalued by 67%.

Key Points:
DXCM Intrinsic Value
Base Case
45.19 USD
Overvaluation 67%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Dexcom Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling DXCM stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Dexcom Inc

Provide an overview of the primary business activities
of Dexcom Inc.

What unique competitive advantages
does Dexcom Inc hold over its rivals?

What risks and challenges
does Dexcom Inc face in the near future?

Has there been any significant insider trading activity
in Dexcom Inc recently?

Summarize the latest earnings call
of Dexcom Inc.

What significant events have occurred
in Dexcom Inc over the past months?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Dexcom Inc.

Provide P/S
for Dexcom Inc.

Provide P/E
for Dexcom Inc.

Provide P/OCF
for Dexcom Inc.

Provide P/FCFE
for Dexcom Inc.

Provide P/B
for Dexcom Inc.

Provide EV/S
for Dexcom Inc.

Provide EV/GP
for Dexcom Inc.

Provide EV/EBITDA
for Dexcom Inc.

Provide EV/EBIT
for Dexcom Inc.

Provide EV/OCF
for Dexcom Inc.

Provide EV/FCFF
for Dexcom Inc.

Provide EV/IC
for Dexcom Inc.

Show me price targets
for Dexcom Inc made by professional analysts.

What are the Revenue projections
for Dexcom Inc?

How accurate were the past Revenue estimates
for Dexcom Inc?

What are the Net Income projections
for Dexcom Inc?

How accurate were the past Net Income estimates
for Dexcom Inc?

What are the EPS projections
for Dexcom Inc?

How accurate were the past EPS estimates
for Dexcom Inc?

What are the EBIT projections
for Dexcom Inc?

How accurate were the past EBIT estimates
for Dexcom Inc?

Compare the revenue forecasts
for Dexcom Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Dexcom Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Dexcom Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Dexcom Inc compared to its peers.

Compare the P/E ratios
of Dexcom Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Dexcom Inc with its peers.

Analyze the financial leverage
of Dexcom Inc compared to its main competitors.

Show all profitability ratios
for Dexcom Inc.

Provide ROE
for Dexcom Inc.

Provide ROA
for Dexcom Inc.

Provide ROIC
for Dexcom Inc.

Provide ROCE
for Dexcom Inc.

Provide Gross Margin
for Dexcom Inc.

Provide Operating Margin
for Dexcom Inc.

Provide Net Margin
for Dexcom Inc.

Provide FCF Margin
for Dexcom Inc.

Show all solvency ratios
for Dexcom Inc.

Provide D/E Ratio
for Dexcom Inc.

Provide D/A Ratio
for Dexcom Inc.

Provide Interest Coverage Ratio
for Dexcom Inc.

Provide Altman Z-Score Ratio
for Dexcom Inc.

Provide Quick Ratio
for Dexcom Inc.

Provide Current Ratio
for Dexcom Inc.

Provide Cash Ratio
for Dexcom Inc.

What is the historical Revenue growth
over the last 5 years for Dexcom Inc?

What is the historical Net Income growth
over the last 5 years for Dexcom Inc?

What is the current Free Cash Flow
of Dexcom Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Dexcom Inc.

Financials

Balance Sheet Decomposition
Dexcom Inc

Current Assets 4.4B
Cash & Short-Term Investments 2.7B
Receivables 987.5m
Other Current Assets 714.3m
Non-Current Assets 1.8B
PP&E 1.2B
Intangibles 159.7m
Other Non-Current Assets 494.4m
Current Liabilities 1.6B
Accounts Payable 276.4m
Accrued Liabilities 1.3B
Other Current Liabilities 25.9m
Non-Current Liabilities 2.6B
Long-Term Debt 2.5B
Other Non-Current Liabilities 147.1m
Efficiency

Earnings Waterfall
Dexcom Inc

Revenue
3.6B USD
Cost of Revenue
-1.3B USD
Gross Profit
2.3B USD
Operating Expenses
-1.7B USD
Operating Income
614.3m USD
Other Expenses
-72.8m USD
Net Income
541.5m USD

Free Cash Flow Analysis
Dexcom Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

DXCM Profitability Score
Profitability Due Diligence

Dexcom Inc's profitability score is 63/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Year Average ROIC
Positive 3-Year Average ROE
Exceptional 3-Years Revenue Growth
63/100
Profitability
Score

Dexcom Inc's profitability score is 63/100. The higher the profitability score, the more profitable the company is.

DXCM Solvency Score
Solvency Due Diligence

Dexcom Inc's solvency score is 78/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Negative Net Debt
78/100
Solvency
Score

Dexcom Inc's solvency score is 78/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

DXCM Price Targets Summary
Dexcom Inc

Wall Street analysts forecast DXCM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DXCM is 154.35 USD with a low forecast of 123.22 USD and a high forecast of 178.5 USD.

Lowest
Price Target
123.22 USD
10% Downside
Average
Price Target
154.35 USD
13% Upside
Highest
Price Target
178.5 USD
31% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

DXCM Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

DXCM Price
Dexcom Inc

1M 1M
-3%
6M 6M
+62%
1Y 1Y
+10%
3Y 3Y
+30%
5Y 5Y
+362%
10Y 10Y
+1 533%
Annual Price Range
136.35
52w Low
75.49
52w High
140.45
Price Metrics
Average Annual Return 45.62%
Standard Deviation of Annual Returns 41.71%
Max Drawdown -58%
Shares Statistics
Market Capitalization 52.5B USD
Shares Outstanding 385 520 000
Percentage of Shares Shorted 4.28%

DXCM Return Decomposition
Main factors of price return

What is price return decomposition?

DXCM News

Other Videos

Last Important Events
Dexcom Inc

Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.

All
Positive
Negative

Sentiment Analysis
Dexcom Inc

Today
Last 7 Days 7D
Last 30 Days 30D
Last 90 Days 90D

Company Profile

Dexcom Inc Logo
Dexcom Inc

Country

United States of America

Industry

Health Care

Market Cap

52.5B USD

Dividend Yield

0%

Description

DexCom, Inc. is a medical device manufacturing company, which engages in the design, development and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. The company is headquartered in San Diego, California and currently employs 6,300 full-time employees. The company went IPO on 2005-04-14. The firm is primarily focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems for use by people with diabetes and by healthcare providers. Its products include Dexcom G6 and Dexcom Share. The G6 is a CGM system that can be used as part of an integrated system with other compatible medical devices and electronic interfaces, which may include automated insulin dosing systems, insulin pumps, blood glucose meters or other electronic devices used for diabetes management. Its Dexcom Share remote monitoring system, offered for use with its Dexcom system, uses an app on the patient’s iPhone, iPod touch, iPad or Android mobile device to securely and wirelessly transmit glucose information to the cloud and then to apps on the mobile devices of up to five designated recipients, who can remotely monitor a patient’s glucose information and receive alert notifications.

Contact

CALIFORNIA
San Diego
6340 Sequence Dr
+18582000200.0
https://www.dexcom.com/

IPO

2005-04-14

Employees

6 300

Officers

Executive Chairman, CEO & President
Mr. Kevin Ronald Sayer
Executive VP, CFO & Chief Accounting Officer
Mr. Jereme M. Sylvain
Executive VP & COO
Mr. Jacob Steven Leach
Executive VP & CTO
Mr. Girish Naganathan
Executive VP & Chief Legal Officer
Mr. Michael Jon Brown
Senior VP & Chief Information Officer
Mr. Shelly Ramasamy Selvaraj
Show More
Director of Corporate Affairs & Head of Investor Relations
Mr. Sean Christensen
Executive Vice President of Strategy, Corporate Development & Dexcom Labs
Mr. Matthew Dolan
Executive Vice President of Marketing
Ms. Leverne Marsh
Executive VP & Chief Human Resources Officer
Ms. Sadie M. Stern
Show Less

See Also

Discover More
What is the Intrinsic Value of one DXCM stock?

The intrinsic value of one DXCM stock under the Base Case scenario is 45.19 USD.

Is DXCM stock undervalued or overvalued?

Compared to the current market price of 136.35 USD, Dexcom Inc is Overvalued by 67%.